Corvis is the pioneer of the all-optical network. Corvis products transmit, route and manage traffic over long distances in the optical domain, virtually eliminating expensive and bandwidth-limiting electronic regeneration and switching equipment and associated operating costs. These and other Faraday media have the ability, when in an appropriate magnetic field, to rotate the plane of linearly polarized light by an amount proportional to its length. YIG crystal is used for wavelengths from 1100 to 2100nm and above. Led by President and CEO, Dr. Dante Marciani, Galenica Pharmaceuticals, Inc. is developing a variety of semi-synthetic and synthetic vaccine adjuvants for human and veterinary medicine.
Vaccines frequently require an adjuvant to stimulate a desired immune response.
In other cases, an appropriate adjuvant can facilitate the development of new vaccines or extend the patent life on a proprietary vaccine by enhancing its efficacy. Management believes Galenica's products will generally be safer and more effective than competing adjuvants and will position the company well in the rapidly growing vaccine market. The company is developing patented technology that enables the design and manufacture of laser modules that generate, process and receive light. LightLogic's technology, based on automated, planar micro manufacturing of active opto-electronic modules, provides a solution that greatly reduces the cost of manufacturing DWDM components. Nufern Established in February 1998, Nufern is the commercial arm of a successful research program at the Australian Photonics Cooperative Research Center.